SCHEMBL23978714

SCHEMBL23978714

C=C(NCc1cccc(CC)c1)c1cc(Cl)c(C(=C)CC)c(Cl)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.35
TXNRD1 Q16881 1/20 0.34
LMNA P02545 2/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
PKM P14618 1/20 0.34
ALOX12 P18054 1/20 0.34
SIGMAR1 Q99720 4/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2D6 P10635 2/20 0.33
MEN1 O00255 1/20 0.33
PLA2G1B P04054 1/20 0.33
CYP1A2 P05177 1/20 0.33
GAA P10253 1/20 0.33
CYP2C19 P33261 1/20 0.33
KMT2A Q03164 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
ATG4B Q9Y4P1 1/20 0.33
CHRM3 P20309 1/20 0.32
F10 P00742 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23978863 0.90 NPC1 (0.41) MAPTALOX12RXFP1
SCHEMBL23979015 0.88 EPHX2 (0.44) P2RY12
SCHEMBL23978881 0.87 MEN1 (0.50) LMNACYP3A4CYP2D6MEN1PLA2G1B
SCHEMBL23979115 0.86 TXNRD1 (0.36) CYP19A1TXNRD1LMNAALDH1A1MAPT
SCHEMBL26507428 0.76 MMP13 (0.40) ALDH1A1MAPTALOX12MEN1CYP2C19
SCHEMBL23978777 0.76 ROCK2 (0.48) CYP3A4CYP2D6MEN1PLA2G1BCYP1A2
SCHEMBL23979023 0.74 ERCC1 (0.45) CHRM3
SCHEMBL23979140 0.72 EPHX2 (0.54) LMNAALDH1A1MEN1KMT2AHPGD
SCHEMBL23978992 0.70 TSHR (0.30)
SCHEMBL14581253 0.68 SMN1; SMN2 (0.43) LMNAALDH1A1MAPTPKMALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021222789-A1 INHIBITORS OF ALPHA 2 BETA 1 INTEGRIN AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-11-04 WO disclosed